about
Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease.Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patientsSOXs in human prostate cancer: implication as progression and prognosis factors.Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.Tumor-derived lymphangiogenic factors and lymphatic metastasis.Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance.Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer.MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.Aberrant activation of hedgehog pathway in nasopharyngeal carcinoma.Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells.Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway.TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer.A 32-gene risk index: a new prognostic approach for prostate cancer progression.Percutaneous nephrolithotomy for renal stones following failed extracorporeal shockwave lithotripsy: different performances and morbidities.CD147 expression indicates unfavourable prognosis in prostate cancer.Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.Proton magnetic resonance spectroscopy in neonates with hypoxic-ischemic injury and its prognostic value.Expression of SOCSs in human prostate cancer and their association in prognosis.HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma.MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.Treatment of lower urethral calculi with extracorporeal shock-wave lithotripsy and pneumatic ureteroscopic lithotripsy: a comparison of effectiveness and complicationsVaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in miceCD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancerIdentification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysisExpression of CD147 is associated with prostate cancer progressionExtracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomasClassical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerCD147 and VEGF expression in advanced renal cell carcinoma and their prognostic valueExtracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancerExpression of hedgehog pathway components is associated with bladder cancer progression and clinical outcomeMicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerDownregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancerExpression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer
P50
Q33497087-8121683E-C437-48C0-BE38-EE705F8CABB4Q33559632-12328841-AFF6-488A-A5D0-35E1B3465274Q34306308-417A024A-0518-4547-97F0-943F85C785CDQ34878192-931274A7-2C9E-4C2E-849D-F0967B0A8472Q36535215-F1679A67-74DA-49B9-A747-60CB0283A434Q36955392-08C999D7-C0C7-40C7-81FB-CBFC6DFA2F66Q37314258-0C466ED5-EA53-4CD8-BF49-5534765DE880Q37500943-CFA6EAE0-2A0A-417D-8320-7E6D3BBCDF75Q37537822-E7C88CCE-391B-4476-AC97-97CE9DCAADB7Q38685838-E1E9D22D-7570-418C-9DE1-F9D008937473Q39185983-E475B6D4-B859-472F-A289-82C4664B864CQ39200185-84FB4AAA-CA62-4A93-9DAE-1260F9523E74Q39273503-62D007F4-65F6-499C-9AC8-19860226D396Q39715031-0160878E-1353-4527-88AD-A1BA8EE151E3Q39924750-80DE82A6-3F78-4EA0-AD93-880C1525253BQ40138388-55539CD3-A119-4D53-A85E-53283876432CQ41852317-7F869A98-31A6-479F-8DF6-35F88B342BB5Q43788925-A6B66BBB-1355-4567-93D2-2118629F8688Q43968053-F736A4F9-73E8-402A-95A7-F535D1A4AD2BQ45350034-CFE04C67-2A23-4BE4-94CD-699EEEA0B179Q46109463-BF334BEA-F4AF-4888-A2C6-689B74D33C94Q46245956-0D95DC9E-2E99-4C64-B392-AFBAC1844541Q46742441-FEEC2394-F55F-4E6F-8855-B58F4F80A479Q47811362-391F4217-89ED-4512-8C72-5A5E0C5A99CDQ51729617-899115F5-32E4-415D-903F-FE903ACDB0EEQ54387126-F771F5BA-047A-47C8-9717-3788FC8E620BQ73733290-238749F1-6E1D-4048-BC93-30E8AE3644DAQ81733390-726511AB-2C97-442B-B05E-37EC8B00F7D1Q82285690-DC8256D8-F607-4290-8D05-832EEBE037F9Q83171676-72409411-CFD7-4895-9718-7396AE88CE87Q83427417-D63F922D-1DB1-4CB6-A734-36DEE6F945D7Q83532352-AA1131B1-F44C-4EE2-8ED4-D77A77C9513DQ83887156-193206F1-C498-4BB0-8957-FDD360B118BBQ84110576-D02B6EBD-76BB-427A-96FE-66CAE67AAC29Q84255040-3E03AE83-2408-40AC-85B9-2F1EEA98D826Q84809628-3C0C4F17-0828-4840-BDBD-306483888FC8Q87146862-50994AF7-9460-48CF-BD57-1BD91C20DCC8Q88804423-39B79B2B-E70D-4498-BACA-9514E9A7DE41Q90404013-FE190E4D-A0E7-4E37-9A11-2D5C8BA5DDE0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Weide Zhong
@ast
Weide Zhong
@en
Weide Zhong
@es
Weide Zhong
@nl
Weide Zhong
@sl
type
label
Weide Zhong
@ast
Weide Zhong
@en
Weide Zhong
@es
Weide Zhong
@nl
Weide Zhong
@sl
prefLabel
Weide Zhong
@ast
Weide Zhong
@en
Weide Zhong
@es
Weide Zhong
@nl
Weide Zhong
@sl
P106
P1153
7402328742
P31
P496
0000-0002-0430-2845